Home/Filings/4/0001209191-18-055688
4//SEC Filing

Stauffer Joseph William 4

Accession 0001209191-18-055688

CIK 0001346830other

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 4:34 PM ET

Size

7.5 KB

Accession

0001209191-18-055688

Insider Transaction Report

Form 4
Period: 2018-10-17
Stauffer Joseph William
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2018-10-17$20.08/sh10,472$210,2782,970 total
  • Sale

    Common Stock

    2018-10-17$20.69/sh970$20,0692,000 total
Footnotes (3)
  • [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 7, 2018.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.60 - $20.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 - $20.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001466459

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:34 PM ET
Size
7.5 KB